Sign in

2 mn vaccinated in a day, tally reaches 28.2mn: Govt

New Delhi The Union health ministry said on Saturday that India administered record 2

Published on: Mar 13, 2021, 23:53:46 IST
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

New Delhi The Union health ministry said on Saturday that India administered record 2.05 million coronavirus vaccine doses a day earlier, taking the total number of shots given so far in the country to 28.2 million.

HT Image
HT Image

Experts, however, say that the vaccination drive needs to be ramped up quickly to break the chain of transmission of Covid-19 and to control the current surge of infections being reported from certain states. “Although it is heartening to see an increase in pace, it is sort of an under-accomplishment to go at this rate as India has the capacity to cover 7 to 10 million per day,” said Dr Giridhara R Babu, head, epidemiology, Indian Institute of Public Health.

India began the Covid-19 vaccination drive, the world’s largest such exercise, on January 16. “India recorded a significant milestone in its countrywide Covid-19 vaccination drive... More than 20 lakh (20,53,537) vaccine doses were given on Day-56 of the vaccination drive (12th March, 2021) through 30,561 sessions. This is the highest single day vaccine administration so far,” said the Union health ministry.

Drugs Controller General of India VG Somani has currently approved two vaccines – Covishield and Covaxin – in the fight against Covid-19. Covaxin is co-developed by Bharat Biotech and the Indian council of Medical’s research and the other vaccine is developed by Oxford-AstraZeneca and is locally manufactured by the Serum Institute of India.

First doses have been administered to 1,639,663 health care and frontline workers, and 413,874 health care and frontline workers have received the second dose of vaccines so far, according to government data.

Since the vaccination was opened in the second phase on on March 1, 7,291,716 individuals above 60 years of age and 1,254,468 between 45 and 59 years with specified comorbidities have been vaccinated in the country. Eight states constituted 74% of the 2,053,537 doses administered in last 24 hours, the Union health ministry said. Uttar Pradesh topped the list with at least 330,000 vaccine doses.

“Covering 10 million people a day will ensure that we will cover the entire vulnerable population within a month. This will prevent any sort of second wave in India. Given the proactive and strong leadership shown by India so far in tackling Covid-19, the ambitious goal to cover them within 30 days will take us ahead of the virus. This ambition is a necessity, not for any records,” Dr Babu said.

India’s caseload stood at 202,022 on Saturday, according to government data. The current caseload is 1.78% of the total positive cases. Maharashtra, Kerala, Punjab, Karnataka, Gujarat, Tamil Nadu and Madhya Pradesh reported 87.72% of the new cases in the last 24 hours. Maharashtra accounts for 63.57% of India’s total active cases.

“Central teams have been rushed to various states that are reporting a surge in cases, and states have been advised to revert to the earlier strategy of test, trace, and treat to curb the chain of transmission. But most important is for people to understand that we must observe Covid-19-appropriate behaviour. It is imperative to wear a mask, observe physical distancing and maintain hygiene as there is still a large section of the population that is susceptible,” said Dr Vinod Paul, member (health), Niti Aayog.

The Union health ministry’s national Covid-19 task force will meet next week to review adverse events following immunisation to check for any reported cases of blood clots or similar side effects in individuals post-vaccination. The ministry held a preliminary meeting with state nodal officers on Saturday for the second consecutive day to collect adverse events data from across the country.

“This raw data will be presented to the national adverse committee for close scrutiny,” said a senior government official directly involved with Covid-19 management.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More